Table 3.
Baseline mean of laboratory assessment in randomized patients.
| Age Group | HCo3 | PCo2 | pH | ALT | AST | Cr | BUN |
|---|---|---|---|---|---|---|---|
| 15-20 N=2 |
23.35±4.17 | 48.75±3.18 | 7.28±0.04 | 14±5.66 | 15.5±6.36 | 0.9 | 17.5±0.7 |
| 21-25 N= 6 |
26.86±3.45 | 46.75±5.63 | 7.36±0.03 | 19±10.8 | 21.5±9.56 | 0.98±0.23 | 24.17±7.02 |
| 26-30 N= 4 |
24.45±2.63 | 42.45±6.4 | 7.36±0.03 | 9.22±5.72 | 13.32±8.73 | 0.95±0.12 | 25±2.82 |
| 31-35 N= 7 |
24.88±2.73 | 44.97±8.37 | 7.38±0.04 | 21.71±10.54 | 23.85±7.33 | 1.01±0.03 | 28±9.38 |
| 36-40 N= 6 |
28.15±3.79 | 53.43±9.35 | 7.35±0.04 | 23.66±20.4 | 28.33±26.88 | 0.96±0.16 | 27±6.78 |
| 41-45 N= 3 |
37.43±14.79 | 48.40±4.78 | 7.37±0.01 | 13.66±12.66 | 13.26±11.69 | 0.8±0.1 | 26±9.53 |
| 46-50 N= 3 |
29.7±1.73 | 48.73±7.21 | 7.4±0.05 | 14.66±4.72 | 17.66±3.51 | 0.9±0.2 | 21.33±11.15 |
| Total N=32 |
27.42±6.03 | 47.56±7.46 | 7.36±0.04 | 17.99±12.31 | 20.47±13.96 | 0.95±0.15 | 25.16±7.54 |
| pValue | .02* | .31 | .07 | .8 | .8 | .3 | .5 |